Charles River to Provide CGT Testing for Magellan Stem Cells
Charles River will provide cGMP NGS viral safety and release testing for Magellan Stem Cells’ Zelestrocel program as it advances toward Phase III and potential commercialization.
Charles River will provide cGMP NGS viral safety and release testing for Magellan Stem Cells’ Zelestrocel program as it advances toward Phase III and potential commercialization.